Feedback (FDBK) Competitors GBX 16.86 +0.11 (+0.63%) (As of 12/20/2024 07:34 AM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider Trades FDBK vs. INHC, IQAI, DVRG, TRLS, SENS, EMIS, CRW, INS, KOO, and RENXShould you be buying Feedback stock or one of its competitors? The main competitors of Feedback include Induction Healthcare Group (INHC), IQ-AI (IQAI), DeepVerge (DVRG), Trellus Health (TRLS), Sensyne Health (SENS), EMIS Group (EMIS), Craneware (CRW), Instem (INS), Kooth (KOO), and Renalytix (RENX). These companies are all part of the "health information services" industry. Feedback vs. Induction Healthcare Group IQ-AI DeepVerge Trellus Health Sensyne Health EMIS Group Craneware Instem Kooth Renalytix Induction Healthcare Group (LON:INHC) and Feedback (LON:FDBK) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, risk, media sentiment, valuation, earnings, community ranking, analyst recommendations, profitability and dividends. Do insiders & institutionals believe in INHC or FDBK? 46.3% of Induction Healthcare Group shares are held by institutional investors. Comparatively, 53.2% of Feedback shares are held by institutional investors. 54.6% of Induction Healthcare Group shares are held by insiders. Comparatively, 10.8% of Feedback shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has stronger earnings & valuation, INHC or FDBK? Induction Healthcare Group has higher revenue and earnings than Feedback. Induction Healthcare Group is trading at a lower price-to-earnings ratio than Feedback, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInduction Healthcare Group£13.65M0.60-£3.25M-£0.03-289.00Feedback£1.18M1.90-£3.30M-£0.25-67.42 Which has more volatility & risk, INHC or FDBK? Induction Healthcare Group has a beta of -0.41, suggesting that its share price is 141% less volatile than the S&P 500. Comparatively, Feedback has a beta of 0.77, suggesting that its share price is 23% less volatile than the S&P 500. Does the media refer more to INHC or FDBK? In the previous week, Induction Healthcare Group's average media sentiment score of 0.00 equaled Feedback'saverage media sentiment score. Company Overall Sentiment Induction Healthcare Group Neutral Feedback Neutral Is INHC or FDBK more profitable? Induction Healthcare Group has a net margin of -23.86% compared to Feedback's net margin of -279.16%. Induction Healthcare Group's return on equity of -14.53% beat Feedback's return on equity.Company Net Margins Return on Equity Return on Assets Induction Healthcare Group-23.86% -14.53% -7.32% Feedback -279.16%-35.63%-22.99% Does the MarketBeat Community believe in INHC or FDBK? Feedback received 151 more outperform votes than Induction Healthcare Group when rated by MarketBeat users. However, 93.33% of users gave Induction Healthcare Group an outperform vote while only 67.07% of users gave Feedback an outperform vote. CompanyUnderperformOutperformInduction Healthcare GroupOutperform Votes1493.33% Underperform Votes16.67%FeedbackOutperform Votes16567.07% Underperform Votes8132.93% SummaryInduction Healthcare Group beats Feedback on 8 of the 13 factors compared between the two stocks. Ad Brownstone ResearchMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. Get Feedback News Delivered to You Automatically Sign up to receive the latest news and ratings for FDBK and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FDBK vs. The Competition Export to ExcelMetricFeedbackHealth Information Services IndustryMedical SectorLON ExchangeMarket Cap£2.25M£196.58M£5.14B£1.90BDividend Yield4.56%6.94%5.09%5.45%P/E Ratio-67.42540.3890.131,863.09Price / Sales1.90285.021,116.25392,686.74Price / Cash1.1247.1443.1028.61Price / Book0.305.074.782.80Net Income-£3.30M-£8.11M£120.31M£155.77M7 Day Performance-5.04%-0.95%-1.92%-2.02%1 Month Performance-17.78%5.83%13.65%21.64%1 Year Performance-75.92%6.32%28.34%29.70% Feedback Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FDBKFeedbackN/AGBX 16.86+0.6%N/A-75.9%£2.25M£1.18M-67.4224High Trading VolumeINHCInduction Healthcare GroupN/AGBX 9-5.3%N/A-61.5%£8.45M£13.65M-316.6774Gap DownIQAIIQ-AIN/AGBX 1.47-2.0%N/A-63.0%£3.26M£538,190.00-13.676Gap UpDVRGDeepVergeN/AGBX 0.15flatN/AN/A£1.14M£12.41M-15.0073TRLSTrellus HealthN/AGBX 0.58-8.0%N/A-82.9%£929,000.00£35,000.00-20.0031Gap DownHigh Trading VolumeSENSSensyne HealthN/AGBX 0.35-33.3%N/AN/A£583,000.00£7.81M-0.0270Gap DownEMISEMIS GroupN/AN/AN/AN/A£1.23B£176.86M4,085.111,560CRWCraneware1.4374 of 5 starsGBX 2,300-1.7%GBX 2,700+17.4%+22.9%£812.82M£189.27M9,192.31734INSInstemN/AGBX 830flatN/AN/A£199.62M£61.63M5,928.57500News CoverageKOOKooth2.2888 of 5 starsGBX 169.50+0.9%GBX 585+245.1%-45.5%£61.83M£54.17M1,416.67478Positive NewsRENXRenalytixN/AGBX 9.50flatN/A-28.9%£15.76M£2.29M-40.63102News Coverage Related Companies and Tools Related Companies INHC Alternatives IQAI Alternatives DVRG Alternatives TRLS Alternatives SENS Alternatives EMIS Alternatives CRW Alternatives INS Alternatives KOO Alternatives RENX Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:FDBK) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Feedback plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Feedback With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
